NCT03170206 2026-02-12
Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
Dana-Farber Cancer Institute
Pfizer
Dana-Farber Cancer Institute
Lebanese University
Emory University
Lebanese University